Infographic: Everest II study “Which is superior? Combination therapy or monotherapy for polypoidal choroidal vasculopathy (PCV) treatment”

被引：0
|
作者：
Chinmayi Himanshuroy Vyas
Pooi Wah Lott
Rubamalar Gunatheesan
Shaun Sebastian Sim
Christopher Ziyu Sun
Kelvin Yi Chong Teo
Chui Ming Gemmy Cheung
机构：
[1] Singapore National Eye Centre,Singapore Eye Research Institute
[2] National University of Singapore,Duke
来源：
Eye | 2022年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1140 / 1141
页数：1
相关论文
共 50 条
  • [21] Real-world cost-effectiveness of anti-VEGF monotherapy and combination therapy for the treatment of polypoidal choroidal vasculopathy
    Chay, Junxing
    Fenner, Beau J.
    Finkelstein, Eric A.
    Teo, Kelvin Y. C.
    Cheung, Chui Ming Gemmy
    EYE, 2022, 36 (12) : 2265 - 2270
  • [22] Comparison of Treatment Outcomes Among Subtypes of Polypoidal Choroidal Vasculopathy in a Multicenter Randomized Controlled Study (EVEREST study)
    Tan, Colin S.
    Lim, Louis Wei Yi
    Ngo, Wei Kiong
    Lim, Tock H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [23] EVEREST study report 4: Fluorescein angiography features predictive of polypoidal choroidal vasculopathy
    Tan, Colin S.
    Ngo, Wei K.
    Lim, Louis W.
    Tan, Nikolle W.
    Lim, Tock H.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 (05): : 614 - 620
  • [24] IRay™ treatment of Polypoidal Choroidal Vasculopathy: a Pilot Study
    Introini, Ugo
    Triolo, Giacinto
    Casalino, Giuseppe
    Bandello, Francesco
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [25] Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for polypoidal choroidal vasculopathy: A systematic review and meta-analysis
    Liu, Lei
    Tham, Yih-Chung
    Wu, Jingyang
    Yue, Song
    Cheng, Ching-Yu
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2017, 20 : 215 - 220
  • [26] Infographic: non-ICGA imaging for polypoidal choroidal vasculopathy (PCV) – Asia-Pacific Ocular Imaging Society PCV workgroup report 1 & 2
    Christopher Ziyu Sun
    Shaun Sebastian Khung Peng Sim
    Chinmayi Himanshuroy Vyas
    Pooi Wah Lott
    Rubamalar Gunatheesan
    Kelvin Yi Chong Teo
    Chui Ming Gemmy Cheung
    Eye, 2022, 36 : 1143 - 1143
  • [27] Infographic: non-ICGA imaging for polypoidal choroidal vasculopathy (PCV) - Asia-Pacific Ocular Imaging Society PCV workgroup report 1 & 2
    Sun, Christopher Ziyu
    Sim, Shaun Sebastian Khung Peng
    Vyas, Chinmayi Himanshuroy
    Lott, Pooi Wah
    Gunatheesan, Rubamalar
    Teo, Kelvin Yi Chong
    Cheung, Chui Ming Gemmy
    EYE, 2022, 36 (06) : 1143 - 1143
  • [28] Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: 24-month results from the EVEREST II study
    Koh, Adrian H. C.
    Parikh, Soumil
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [29] Choroidal morphology and short-term outcomes of combination photodynamic therapy in polypoidal choroidal vasculopathy
    Jiwon Baek
    Jae Hyung Lee
    Sohee Jeon
    Won Ki Lee
    Eye, 2019, 33 : 419 - 427
  • [30] Anatomical outcomes of ranibizumab 0.5 mg combined with verteporfin photodynamic therapy vs ranibizumab monotherapy in patients with polypoidal choroidal vasculopathy: 12-month results from the EVEREST II study
    Lai, Timothy Y. Y.
    Feller, Chrystel
    Margaron, Philippe
    Tan, Colin S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
12345